Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $91.1063 (0.42%) ($90.3552 - $91.6102) on Wed. Nov. 29, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.65% (three month average) | RSI | 49 | Latest Price | $91.1063(0.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(50%) IVE(48%) SPY(48%) IWD(47%) | Factors Impacting ABBV price | ABBV will decline at least -0.825% in a week (0% probabilities). VIXM(-18%) TLT(-14%) UUP(-10%) IGOV(-4%) DIA(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.825% (StdDev 1.65%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
5 Day Moving Average | $90.49(0.68%) | 10 Day Moving Average | $89.98(1.25%) | 20 Day Moving Average | $89.69(1.58%) | To recent high | -0.7% | To recent low | 30.6% | Market Cap | $160.737b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |